The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis

Blood

Volumn 120, Issue 25, 2012, Pages 5063-5072

  Bridge, Gemma ^a   Monteiro, Rui ^b   Henderson, Stephen ^a   Emuss, Victoria ^a   Lagos, Dimitris ^c   Georgopoulou, Dimitra ^a   Patient, Roger ^b   Boshoff, Chris ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA LIKE 4; MICRORNA; MICRORNA 30; MICRORNA 30B; MICRORNA 30C; NOTCH RECEPTOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANGIOGENESIS; ARTICLE; CELL FUNCTION; EMBRYO; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; KAPOSI SARCOMA; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ZEBRA FISH;

EID: 84871038819     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-423004     Document Type: Article

References (50)

1. Gridley T. Notch signaling in the vasculature. In: Raphael K, ed. Current Topics in Developmental Biology Notch Signaling. Vol 92. Waltham, MA: Academic Press; 2010:277-309.
2. Phng LK, Gerhardt H. Angiogenesis: a team effort coordinated by Notch. Dev Cell. 2009;16(2):196-208.
3. Gale NW, Dominguez MG, Noguera I, et al. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci U S A. 2004;101(45):15949-15954. (Pubitemid 39507907)
4. Hellström M, Phng LK, Hofmann JJ, et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature. 2007; 445(7129):776-780. (Pubitemid 46279716)
5. Leslie JD, Ariza-McNaughton L, Bermange AL, McAdow R, Johnson SL, Lewis J. Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development. 2007;134(5):839-844. (Pubitemid 46795675)
6. Siekmann AF, Lawson ND. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature. 2007;445(7129):781-784. (Pubitemid 46279717)
7. Jubb AM, Soilleux EJ, Turley H, et al. Expression of vascular Notch ligand Delta-like 4 and inflammatory markers in breast cancer. Am J Pathol. 2010;176(4):2019-2028.
8. Patel NS, Li JL, Generali D, Poulsom R, Cranston DW, Harris AL. Up-regulation of Deltalike 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res. 2005;65(19):8690- 8697. (Pubitemid 41377356)
9. Patel NS, Dobbie MS, Rochester M, et al. Upregulation of endothelial Delta-like 4 expression correlates with vessel maturation in bladder cancer. Clin Cancer Res. 2006;12(16):4836-4844. (Pubitemid 44338568)
10. Noguera-Troise I, Daly C, Papadopoulos NJ, et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature. 2006;444(7122):1032-1037. (Pubitemid 46018516)
11. Ridgway J, Zhang G, Wu Y, et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature. 2006;444(7122):1083-1087. (Pubitemid 46018529)
12. Emuss V, Lagos D, Pizzey A, Gratrix F, Henderson SR, Boshoff C. KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia. PLoS Pathog. 2009;5(10):e1000616.
13. Liu R, Li X, Tulpule A, et al. KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood. 2010; 115(4):887-895.
14. Wang HW, Trotter MWB, Lagos D, et al. Kaposi sarcoma herpes virus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet. 2004;36(7):687-693. (Pubitemid 38886628)
15. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136(4):642-655.
16. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10(10):704-714.
17. Wang S, Olson EN. AngiomiRs-key regulators of angiogenesis. Curr Opin Genet Dev. 2009;19(3):205-211.
18. Biyashev D, Veliceasa D, Topczewski J, et al. miR-27b controls venous specification and tip cell fate. Blood. 2012;119(11):2679-87.
19. Urbich C, Kaluza D, Frömel T, et al. MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood. 2012;119(6):1607-1616.
20. Lagos D, Pollara G, Henderson S, et al. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol. 2010;12(5):513-519.
21. Lewis BP, Shih IH, Jones-RhoadesMW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115(7):787-798. (Pubitemid 38058492)
22. Vieira J, O'Hearn P, Kimball L, Chandran B, Corey L. Activation of Kaposi's sarcoma-associated herpes virus (Human Herpes virus 8) lytic replication by human cytomegalovirus. J Virol. 2001;75(3):1378-1386. (Pubitemid 32094696)
23. Vart RJ, Nikitenko LL, Lagos D, et al. Kaposi's sarcoma-associated herpes virus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Cancer Res. 2007;67(9):4042-4051. (Pubitemid 46815049)
24. Weber H, Claffey J, Hogan M, Pampillón C, Tacke M. Analyses of Titanocenes in the spheroid-based cellular angiogenesis assay. Toxicol In Vitro. 2008;22(2):531-534. (Pubitemid 351163538)
25. Westerfield M. The zebrafish book; a guide for laboratory use of zebrafish (Brachydanio rerio). Eugene, OR: University of Oregon Press; 1993.
26. Beis D, Bartman T, Jin SW, et al. Genetic and cellular analyses of zebrafish atrioventricular cushion and valve development. Development. 2005; 132(18):4193-4204. (Pubitemid 41488867)
27. Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol. 2002;248(2):307-318. (Pubitemid 35002091)
28. Bahary N, Goishi K, Stuckenholz C, et al. Duplicate VegfA genes and orthologues of the KDR receptor tyrosine kinase family mediate vascular development in the zebrafish. Blood. 2007; 110(10):3627-3636. (Pubitemid 350159631)
29. Choi WY, Giraldez AJ, Schier AF. Target protectors reveal dampening and balancing of nodal agonist and antagonist by miR-430. Science. 2007;318(5848):271-274. (Pubitemid 47574854)
30. Jowett T, Yan Y-L. Double fluorescent in situ hybridization to zebrafish embryos. Trends Genet. 1996;12(10):387-389. (Pubitemid 26336473)
31. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:article 3.
32. Mesri EA, Cesarman E, Boshoff C. Kaposi's sarcoma and its associated herpes virus. Nat Rev Cancer. 2010;10(10):707-719.
33. Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27(1):91-105. (Pubitemid 46991392)
34. Wang Z, Li Y, Kong D, Ahmad A, Banerjee S, Sarkar FH. Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Lett. 2010;292(2):141-148.
35. Braun J, Hoang-Vu C, Dralle H, Hüttelmaier S. Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene. 2010;29(29):4237-4244.
36. Yu F, Deng H, Yao H, Liu Q, Su F, Song E. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene. 2010;29(29):4194-4204.
37. Khan AA, Betel D, Miller ML, Sander C, Leslie CS, Marks DS. Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat Biotechnol. 2009;27(6):549-555.
38. Harrington LS, Sainson RCA, Williams CK, et al. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvasc Res. 2008;75(2):144-154. (Pubitemid 351249857)
39. Wienholds E, Kloosterman WP, Miska E, et al. MicroRNA expression in zebrafish embryonic development. Science. 2005;309(5732):310-311. (Pubitemid 40967869)
40. Ellertsdóttir E, Lenard A, Blum Y, et al. Vascular morphogenesis in the zebrafish embryo. Dev Biol. 2010;341(1):56-65.
41. Chen PY, Manninga H, Slanchev K, et al. The developmental miRNA profiles of zebrafish as determined by small RNA cloning. Genes Dev. 2005; 19(11):1288-1293. (Pubitemid 41003018)
42. Li JL, Sainson RCA, Shi W, et al. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res. 2007;67(23):11244-11253. (Pubitemid 350248550)
43. Bussmann J, Lawson N, Zon L, Schulte-Merker S, Zebrafish Nomenclature Committee. Zebrafish VEGF receptors: a guideline to nomenclature. PLoS Genet. 2008;4(5):e1000064.
44. Wu T, Zhou H, Hong Y, Li J, Jiang X, Huang H. miR-30 family members negatively regulate osteoblast differentiation. J Biol Chem. 2012; 287(10):7503-7511.
45. Zaragosi L-E, Wdziekonski B, Le Brigand K, et al. Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol. 2011;12(7):R64.
46. Zhang J, Zhang H, Liu J, et al. miR-30 inhibits TGF- 1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Biochem Biophys Res Commun. 2012;417(3):1100-1105.
47. Agrawal R, Tran U, Wessely O. The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1. Development. 2009;136(23):3927-3936.
48. Martinez I, Cazalla D, Almstead LL, Steitz JA, DiMaio D. miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci U S A. 2011;108(2):522-527.
49. Duisters RF, Tijsen AJ, Schroen B, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res. 2009; 104(2):170-178.
50. Lin J, Lwin T, Zhao JJ, et al. Follicular dendritic cell-induced microRNA-mediated up-regulation of PRDM1 and downregulation of BCL-6 in non- Hodgkin's B-cell lymphomas. Leukemia. 2011; 25(1):145-152.